The Gavi Leap
Transforming the Vaccine Alliance for the future through simplicity, transparency and synergy, paving the way for a ‘Global Health Leap’.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreHow Ondo State is confronting Nigeria’s changing Lassa fever threat
It’s deadly, and it’s becoming less predictable. Health workers working on the Lassa fever isolation ward say, “We cannot let our guard down.”
Pharmacogenomics: how your genes could help doctors choose the right medicine and dose
Your genes can affect how some medicines work. A reusable result could help doctors prescribe more safely, alongside other clinical evidence.
Too hot to learn: how climate change hurts children’s chances from birth
Floods, droughts and extreme heat can disrupt nutrition and healthcare in early life, with consequences that may last for years.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allNew “blockbuster” tuberculosis vaccines could save seven million lives by 2050
Next-generation TB vaccines, expected to become available from 2029, could deliver major health and economic gains, helping to save an estimated 7.3 million lives, generate up to US$ 135 billion in economic benefits for low-and middle-income…
Gavi welcomes prequalification of multi-dose RSV maternal vaccine to protect infants
WHO prequalification of a multi-dose RSV maternal vaccine marks a major step towards protecting newborns and infants from one of the leading causes of severe respiratory illness, hospitalisation and death worldwide.
Papua New Guinea launches HPV vaccination to protect girls from cervical cancer
Cervical cancer remains one of the leading causes of cancer-related deaths for women in Papua New Guinea, with over 1,000 women diagnosed and ~650 deaths annually.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
